Campbell & CO Investment Adviser LLC
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1353570
BALTIMORE, MD
Position in AMLX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,813,295
+$1,056,830 QoQ
Shares Held
100,963
+85.5% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#82
of 207 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Campbell & CO Investment Adviser LLC holds $22,192,108 across 17 Drug Manufacturers - Specialty & Generic names. AMLX ranks #4 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
13,309 | $7,211,215 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
69,871 | $2,866,807 | |
| 3 | PRGO |
PERRIGO Co plc
|
200,105 | $2,079,090 | |
| 4 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
100,963 | $1,813,295 | |
| 5 | ZTS |
Zoetis Inc.
|
23,125 | $1,661,762 | |
| 6 | HROW |
Harrow, Inc.
|
36,286 | $1,541,066 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
45,378 | $1,116,752 | |
| 8 | PBH |
Prestige Consumer Healthcare Inc.
|
19,175 | $906,402 |
All Filings in AMLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,813,295 | 100,963 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $756,465 | 54,422 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $951,457 | 78,763 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $332,710 | 24,482 | Shares | Sole | 2025-10-28 | |
| No filing history on record for this holder in this stock. | ||||||